Biotech Catches Major Premarket Bid Following FDA Approval
03 Abril 2024 - 8:25AM
AllPennyStocks.com
A Washington D.C.-based biotech is causing
quite the stir so far during Wednesday’s premarket after the
company’s Fanapt received FDA approval for the acute
treatment...
To read the full story on AllPennyStocks.com, click
here.
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfica de Acción Histórica
De Abr 2024 a May 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
Gráfica de Acción Histórica
De May 2023 a May 2024